ABSTRACT

KEYWORDS

REFERENCES

1. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413.

2. ATS “Pulmonary Rehabilitation 1999”. Am J Respir Crit Care Med 1999; 159: 1666-1682.

3. Pulmonary rehabilitation guidelines panel: American College of Chest Physicians and American Association of Cardiovascular and Pulmonary Rehabilitation. Pulmonary Rehabilitation. Chest 1997; 112: 1363-1396.

4. The COPD guidelines group of the standards of care committee of the ATS. Thorax 1997; 52: 25S.

5. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Document 2006. NHLB/WHO Global initiative for chronic lung Disease. www.goldcopd.org

6. BTS “Pulmonary Rehabilitation Standards of care subcommittee on Pulmonary Rehabilitation”. Thorax 2001; 56: 827-834.

7. Donner C. Pulmonary Rehabilitation ERS. Volume 5 Monograph 13 march 2000.

8. Nichol K, Margolis K, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778-784.

9. Simberkoff MS, Cross AP, Al-Ibrahim M, Ballch AL, Geiseler PJ, et al. Efficacy of pneumococcal vaccine in high-risk patients. Results of a veterans administration cooperative study. N Engl J Med 1986; 315: 1318-1327.

10. Jackson LA, Neuzil KM, YU O, Benson P, Barlow WE, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348: 1747-1755.